Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Olav Wendelboe Nielsen a Cardiovascular Department, Copenhagen
University Hospital Hvidovre, DK-2650 Hvidovre, Denmark, b Department of Biostatistics, Panum
Institute, Copenhagen University, Copenhagen, Denmark, c Department of Clinical
Biochemistry, Odense University Hospital, Odense, Denmark
Correspondence to: O
Wendelboe Nielsen own{at}dadlnet.dk
| |
Abstract |
|---|
|
|
|---|
Objectives:
To assess the probability of left
ventricular systolic dysfunction without echocardiography in patients
from general practice.
Design:
Cross sectional study using multivariate
regression models to examine the relation between clinical variables
and left ventricular systolic dysfunction as determined by echocardiography.
Setting:
Three general practices in Copenhagen.
Subjects:
2158 patients aged >40 years were screened by questionnaires and case record reviews; 357 patients with past or
present signs or symptoms of heart disease were identified, of whom 126 were eligible for and consented to examination.
Main outcome measures:
Clinical variables that were
significantly (P<0.05) related to ejection fraction
0.45 and their
predictive value for left ventricular systolic dysfunction.
Results:
15 patients (12%) had left ventricular
systolic dysfunction. The prevalence was significantly related to three questions: does the electrocardiogram have Q waves, left bundle branch block, or ST-T segment changes? (P=0.012); is resting supine heart rate greater than the simultaneous diastolic blood pressure? (P=0.002); and is plasma N-terminal atrial natriuretic
peptide>0.8 nmol/l? (P=0.040)? Only one of 60 patients with a normal
electrocardiogram had systolic dysfunction (2%, 95% confidence
interval 0% to 9%) regardless of response to the other two questions.
The risk of dysfunction was appreciable in patients with a yes answer
to two or three questions (50%, 27% to 73%).
Conclusions:
A normal electrocardiogram implies a low
risk of left ventricular systolic dysfunction. Patients can be
identified for echocardiography on the basis of an abnormal
electrocardiogram combined with increased natriuretic peptide
concentration or a heart rate greater than diastolic blood pressure, or both.
|
Key messages
|
| |
Introduction |
|---|
|
|
|---|
Identification and treatment of patients with left
ventricular systolic dysfunction improves survival and reduces
morbidity.1-5 About 3% of the adult population have
systolic dysfunction,6-8 but half of them are
asymptomatic and can be identified only by objective methods, usually
echocardiography. Identification consequently rests on selecting the
right patients for echocardiography. Patients with a history of
ischaemic heart disease are an obvious risk group,6 but
greater sensitivity is achieved by examining anyone with signs
suggestive of heart disease. The purpose of the study was to examine
how primary care doctors might identify patients at increased risk of
systolic dysfunction in order to decide who to refer for
echocardiography. We evaluated simple and inexpensive clinical methods
that can be used in general practice.
| |
Subjects and methods |
|---|
|
|
|---|
Patients
This study is a substudy of a cross-sectional survey that
aimed to determine the prevalence of heart failure in general practice.
The required population size was calculated as 2200 to give a standard
error of about 0.5% on the estimate of heart failure prevalence. We
asked the National Health Insurance Register for names and
addresses of all patients over 40 years of age who were registered with
three general practices on three separate dates in 1993 to 1995. The
practices were chosen because they had used the same computer
program for case notes (Docbase, Roskilde, Denmark) over two to
four years and because they were situated in geographically and
socially different areas of Copenhagen. The study was approved by
the local ethics committee, and all examined patients gave informed consent.
Clinical examination
All patients had a physical examination, chest radiography,
echocardiography, supine 12 lead electrocardiography, blood pressure
measurements, and blood samples taken. OW and JFH independently coded
the electrocardiograms using the Minnesota system9 without
knowing the patient's clinical status.
Echocardiography
Left ventricular ejection fraction was indirectly estimated
from the fractional shortening
10 11
or from a nine segment model for assessing wall motion index score.
12 13
Left ventricular systolic dysfunction is indicated by a wall motion index score below 1.5 or a fractional shortening below 0.26
that is,
roughly an ejection fraction below 0.45. Left ventricular ejection
fraction values were determined from videotapes and
photoechocardiograms at the end of the study by OW, who was blinded to
other clinical data. The intraobserver and interobserver (CTL
v OW) standard deviations for a single ejection fraction
estimate were equal (0.05 units, coefficient of variation=8%).
N-terminal atrial natriuretic peptide
Concentrations of N-terminal atrial natriuretic peptide were determined from frozen stored plasma samples with a
commercial radioimmunoassay (OY NT-pro-ANP 125I
radioimmunoassay, Biotop, Helsinki, Finland). Plasma samples were drawn
after 10 minutes' supine rest and analysed within 12 months. The
combined between assay and within assay coefficient of variation was
3.7%. The normal range was obtained from 22 patients who, after
examination, were concluded to have normal cardiac function. The mean
concentration plus 2 SD in these 22 patients was 0.77 nmol/l, so values
above 0.8 nmol/l were defined as abnormal.
Statistical analysis
Predictive markers of left ventricular systolic dysfunction (ejection fraction
0.45) were identified by the
2 test with Yates's continuity correction and a
multiple linear regression model against the natural logarithm of
ejection fraction. The logarithmic transformation was used to weight
variables operating on the important lower ejection fraction spectrum.
To reduce the risk of chance findings, we maintained only variables
that were significant in two equally sized random subsets after sex and systolic dysfunction had been stratified for. Finally, a logistic regression model was used to make a clinically useful algorithm. The
computer package Statistica (Statsoft, Tulsa, USA) was used for all
calculations, and P values <0.05 in two sided tests were considered
significant. Confidence limits around percentages were derived from the
binomial distribution.
| |
Results |
|---|
|
|
|---|
Study population
We screened 2158 patients from three general practices; the
demographic and socioeconomic characteristics were similar to those of
the total Copenhagen population. About 2.5% (55) had a blank or
missing case record. These were coded as cardiac healthy unless the
questionnaire indicated otherwise. The questionnaire was returned by
87% (1504/1757) of patients aged 40 to 80 years. But among patients
aged over 80 years, 48% (191/401) either did not respond or
were resident in nursing homes. Nursing home residents had more heart
disease than respondents, but it was often of unknown cause. The
prevalence of a history of heart disease was similar in non-respondents
and respondents.
|
|
Univariate markers of systolic dysfunction
Table 3 shows that a normal electrocardiogram indicates a
normal systolic function and that systolic dysfunction can occur
despite a normal plasma concentration of N-terminal atrial
natriuretic peptide. The interaction term "heart rate greater than
diastolic blood pressure" was superior to both heart rate and blood
pressure individually. We initially evaluated "heart rate minus
diastolic blood pressure" in the
2 test using
various cut off values because we had noted that heart rate and
diastolic blood pressure were oppositely related to ejection fraction
with numerically similar coefficients. A zero difference predicted
systolic dysfunction best, hence we used a "greater than" relation.
A history of heart failure and myocardial infarction were not as
significantly associated with systolic dysfunction. Dyspnoea, chest
radiography, and results of the physical examination were not
significantly associated with systolic dysfunction
(P>0.1).
|
Multivariate regression analysis
The logarithm of ejection fraction was inversely associated
with N-terminal atrial natriuretic peptide concentration, heart rate, history of myocardial infarction (P<0.001), left bundle branch block in the electrocardiogram (P<0.002), history of heart failure, and Q waves in the electrocardiogram; it was positively associated with diastolic blood pressure and female sex (P<0.05). Sex
and history of heart failure were eliminated because they were not
significant in both patient subsets. The remaining significant variables were then used to form three clinically useful "yes or
no" questions (table 4). Table 5 shows how to combine questions to
assess the risk of systolic dysfunction. The probability of systolic
dysfunction was very low if the patient had a normal electrocardiogram,
regardless of the other questions. The probability increased if an
abnormal electrocardiogram was accompanied by another positive answer,
with a yes to all three questions being most
specific.
|
|
| |
Discussion |
|---|
|
|
|---|
We evaluated a range of simple diagnostic tests to assess the risk of left ventricular systolic dysfunction in 126 patients from primary care with past or present signs or symptoms of heart disease. A normal electrocardiogram was the only clinically useful test to rule out systolic dysfunction with a sufficiently high accuracy. No single test could diagnose systolic dysfunction. Combined use of heart rate, diastolic blood pressure, and N-terminal atrial natriuretic peptide concentration in patients with an abnormal electrocardiogram, however, was accurate enough to be used to identify patients who should or should not be referred for echocardiography. Those with "yes" to all questions may be treated as if they have systolic dysfunction while waiting for the results of echocardiography, since they almost certainly will have it.
The electrocardiogram was the most useful test in this stable population from primary care. This has also been found true for patients referred for open access echocardiography,14 in a general population,15 and in referred patients with chest pain,16 dyspnoea,17 and myocardial infarction. 18 19 As in a recent study of stable myocardial infarction patients from primary care,20 we found that a single measurement of plasma N-terminal atrial natriuretic peptide could not discriminate between minor degrees of systolic dysfunction and preserved systolic function. Measuring brain natriuretic peptide instead would probably not have changed our conclusions, since it has only a slightly higher association with systolic dysfunction than N-terminal atrial natriuretic peptide. 15 20 21 The close relation between heart rate and blood pressure gives reason for a joint assessment. Although the combined variable was highly significant (tables 3 and 4), it should be used with caution until it has been validated in other settings.
Application of results
Our results are robust because the two independent regression models minimised risk of finding significant variables by
chance and because we used unbiased ejection fraction values and a
clinically relevant study population for screening. We would probably
have identified more variables with a higher significance if we had
studied more patients and used a more reproducible measurement of
ejection fraction than echocardiography. The algorithm will probably
identify fewer false positives results if applied to a hospital
outpatient population, where the prevalence of systolic dysfunction is
higher. This screening method needs to be compared with other screening
methods in a prospective randomised controlled trial with different
samples of patients; the trial should incorporate a health economic
evaluation. Other screening methods could be simplified
echocardiography,22 computerised heart auscultation, or
new biochemical markers.
| |
Acknowledgments |
|---|
We thank Hans Frimodt-Møller, Hans-Christian Møller, Christen Myrup, and Erik Schiøttz-Christensen for allowing us access to their general practice case notes. We also thank the patients and cardiac technician Kirsten Andersen for obtaining blood samples and electrocardiograms.
Contributors: OWN initiated and coordinated the primary study hypothesis, discussed core ideas, designed the protocol, collected the data, performed the analyses, and wrote the paper. JFH discussed core ideas and design and participated in clinical analyses and writing of the paper. JH discussed core ideas and design and participated in statistical analyses and writing the paper. CTL supervised the echocardiography, participated in a reproducibility study, and edited the paper. JS analysed natriuretic peptide and edited the paper. OWN and JFH will act as guarantors.
| |
Footnotes |
|---|
Funding: Danish Heart Foundation.
Competing interests: None declared.
| |
References |
|---|
|
|
|---|
| 1. |
Bristow MR, Gilbert EM, Abraham WT, Adams KP, Fowler MB, Hershberger RE, et al.
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure (MOCHA investigators).
Circulation
1996;
94:
2807-2816 |
| 2. | SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-691[Abstract]. |
| 3. | CIBIS-II Investigators. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 1999; 353: 9-13[CrossRef][Medline]. |
| 4. | SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302[Abstract]. |
| 5. | Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators. N Engl J Med 1992; 327: 669-677[Abstract]. |
| 6. | McDonagh TA, Morrison CE, Lawrence A, Ford I, Tunstall-Pedoe H, McMurray JJ, et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet 1997; 350: 829-833[CrossRef][Medline]. |
| 7. | Mosterd A, de BM, Hoes AW, Deckers JW, Hofman A, Grobbee DE. Usefulness of echocardiography in detecting left ventricular dysfunction in population-based studies (the Rotterdam study). Am J Cardiol 1997; 79: 103-104[CrossRef][Medline]. |
| 8. | Wendelboe O, Hansen JF, Hilden J. The prevalence of heart failure in relation to a symptom-based diagnosis, echocardiography, and a primary to secondary care-based diagnosis [abstract]. Eur Heart J 1998; 19: 249. |
| 9. | Rose GA, Blackburn H. Minnesota code for resting electrocardiograms. classification of the electrocardiogram for population studies. Circulation 1960; 21: 137-188. |
| 10. |
Quinones MA, Waggoner AD, Reduto LA, Nelson JG, Young JB, Winters WL, et al.
A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography.
Circulation
1981;
64:
744-753 |
| 11. |
Sahn DJ, DeMaria A, Kisslo J, Weyman A.
Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.
Circulation
1978;
58:
1072-1083 |
| 12. | Berning J, Rokkedal NJ, Launbjerg J, Fogh J, Mickley H, Andersen PE. Rapid estimation of left ventricular ejection fraction in acute myocardial infarction by echocardiographic wall motion analysis. Cardiology 1992; 80: 257-266[Medline]. |
| 13. |
Kober L, Torp-Pedersen C, Carlsen J, Videbaek R, Egeblad H.
An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multicentre studies (as used in the TRACE study). Trandolapril cardiac evaluation.
Eur Heart J
1994;
15:
1616-1620 |
| 14. |
Davie AP, Francis CM, Love MP, Caruana L, Starkey IR, Shaw TR, et al.
Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction.
BMJ
1996;
312:
222-225 |
| 15. | McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998; 351: 9-13[CrossRef][Medline]. |
| 16. | Rihal CS, Davis KB, Kennedy JW, Gersh BJ. The utility of clinical, electrocardiographic, and roentgenographic variables in the prediction of left ventricular function. Am J Cardiol 1995; 75: 220-223[CrossRef][Medline]. |
| 17. |
Gillespie ND, McNeill G, Pringle T, Ogston S, Struthers AD, Pringle SD.
Cross sectional study of contribution of clinical assessment and simple cardiac investigations to diagnosis of left ventricular systolic dysfunction in patients admitted with acute dyspnoea.
BMJ
1997;
314:
936-940 |
| 18. | McNamara RF, Carleen E, Moss AJ. Estimating left ventricular ejection fraction after myocardial infarction by various clinical parameters. Am J Cardiol 1988; 62: 192-196[CrossRef][Medline]. |
| 19. |
Silver MT, Rose GA, Paul SD, O'Donnell CJ, O'Gara PT, Eagle KA.
A clinical rule to predict preserved left ventricular ejection fraction in patients after myocardial infarction.
Ann Intern Med
1994;
121:
750-756 |
| 20. |
McClure S, Caruana L, Davie AP, Goldthorp S, McMurray JJ.
Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care.
BMJ
1998;
317:
516-519 |
| 21. |
McDonagh TA, Morrison CE, McMurray JJV, Dargie HJ.
Screening with natriuretic peptides to detect a wall motion score index of 1.2 [abstract].
Eur Heart J
1997;
suppl19:
597.
|
| 22. | Willenheimer RB, Israelsson BA, Cline CM, Erhardt LR. Simplified echocardiography in the diagnosis of heart failure. Scand Cardiovascular J 1997; 31: 9-16[Medline]. |
| 23. | Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997; 350: 1349-1353[CrossRef][Medline]. |
| 24. |
Morgan S, Smith H, Simpson I, et al.
Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross sectional survey.
BMJ
1999;
318:
368-372 |
(Accepted 1 November 1999)
Read all Rapid Responses